Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George Giotopoulos

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Nature Communications|May 20, 2025
CREBBP inactivation sensitizes B cell acute lymphoblastic leukemia to ferroptotic cell death upon BCL2 inhibitionAlicia Garcia-Gimenez, Jonathan E Ditcham, Dhoyazan M A Azazi, et al.
Nature Communications|April 14, 2023
Mannose metabolism inhibition sensitizes acute myeloid leukaemia cells to therapy by driving ferroptotic cell deathKeith Woodley, Laura S Dillingh, George Giotopoulos, et al.
Nature Genetics|August 14, 2023
In vivo screening characterizes chromatin factor functions during normal and malignant hematopoiesisDavid Lara-Astiaso, Ainhoa Goñi-Salaverri, Julen Mendieta-Esteban, et al.
Cancers|December 11, 2019
Novel and Rare Fusion Transcripts Involving Transcription Factors and Tumor Suppressor Genes in Acute Myeloid LeukemiaAntonella Padella, Giorgia Simonetti, Giulia Paciello, et al.
Cell Genomics|December 20, 2023
Preleukemic single-cell landscapes reveal mutation-specific mechanisms and gene programs predictive of AML patient outcomesTomoya Isobe, Iwo Kucinski, Melania Barile, et al.
Nature|October 4, 2011
Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemiaMark A Dawson, Rab K Prinjha, Antje Dittmann, et al.
Blood|June 25, 2025
Posttranscriptional depletion of ribosome biogenesis factors engenders therapeutic vulnerabilities in NPM1-mutant AMLAristi Damaskou, Rachael Wilson, Malgorzata Gozdecka, et al.
Blood|December 9, 2024
Acute resistance to BET inhibitors remodels compensatory transcriptional programs via p300 coactivationViral Shah, George Giotopoulos, Hikari Osaki, et al.
Nature Biotechnology|April 24, 2025
Treatment of acute myeloid leukemia models by targeting a cell surface RNA-binding proteinBenson M George, Maria Eleftheriou, Eliza Yankova, et al.
Nature|September 15, 2015
BET inhibitor resistance emerges from leukaemia stem cellsChun Yew Fong, Omer Gilan, Enid Y N Lam, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Nature Communications|May 20, 2025
CREBBP inactivation sensitizes B cell acute lymphoblastic leukemia to ferroptotic cell death upon BCL2 inhibitionAlicia Garcia-Gimenez, Jonathan E Ditcham, Dhoyazan M A Azazi, et al.
Nature Communications|April 14, 2023
Mannose metabolism inhibition sensitizes acute myeloid leukaemia cells to therapy by driving ferroptotic cell deathKeith Woodley, Laura S Dillingh, George Giotopoulos, et al.
Nature Genetics|August 14, 2023
In vivo screening characterizes chromatin factor functions during normal and malignant hematopoiesisDavid Lara-Astiaso, Ainhoa Goñi-Salaverri, Julen Mendieta-Esteban, et al.
Cancers|December 11, 2019
Novel and Rare Fusion Transcripts Involving Transcription Factors and Tumor Suppressor Genes in Acute Myeloid LeukemiaAntonella Padella, Giorgia Simonetti, Giulia Paciello, et al.
Cell Genomics|December 20, 2023
Preleukemic single-cell landscapes reveal mutation-specific mechanisms and gene programs predictive of AML patient outcomesTomoya Isobe, Iwo Kucinski, Melania Barile, et al.
Nature|October 4, 2011
Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemiaMark A Dawson, Rab K Prinjha, Antje Dittmann, et al.
Blood|June 25, 2025
Posttranscriptional depletion of ribosome biogenesis factors engenders therapeutic vulnerabilities in NPM1-mutant AMLAristi Damaskou, Rachael Wilson, Malgorzata Gozdecka, et al.
Blood|December 9, 2024
Acute resistance to BET inhibitors remodels compensatory transcriptional programs via p300 coactivationViral Shah, George Giotopoulos, Hikari Osaki, et al.
Nature Biotechnology|April 24, 2025
Treatment of acute myeloid leukemia models by targeting a cell surface RNA-binding proteinBenson M George, Maria Eleftheriou, Eliza Yankova, et al.
Nature|September 15, 2015
BET inhibitor resistance emerges from leukaemia stem cellsChun Yew Fong, Omer Gilan, Enid Y N Lam, et al.
Pageof 4